CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,017 Cr | ₹853 Cr | ₹71 Cr | ₹617 Cr | ₹5,123 Cr |
What is the latest Revenue of CONCORD BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,017 Cr |
| Mar2024 | ₹853 Cr |
| Mar2023 | ₹71 Cr |
| Mar2022 | ₹617 Cr |
| Mar2021 | ₹5,123 Cr |
How is Revenue of CONCORD BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,017 Cr | 19.20 | |
| Mar2024 | ₹853 Cr | 1,096.71 | |
| Mar2023 | ₹71 Cr | -88.44 | |
| Mar2022 | ₹617 Cr | -87.96 | |
| Mar2021 | ₹5,123 Cr | - | |
Compare Revenue of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,425.4 Cr | 8.7% | -2.8% | -43.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,698.0 Cr | 0.2% | -1.3% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,866.0 Cr | 1.9% | -6.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | 1.3% | 2.9% | 28.7% | Stock Analytics | |
| CIPLA | ₹108,412.0 Cr | 1.3% | -8.5% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,805.0 Cr | 1.3% | 3.8% | 4.5% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 8.7% |
-2.8% |
-43.4% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses